Our response to the PERT shortages

We are aware of and concerned about the stress and anxiety that shortages of pancreatic enzyme replacement therapy (PERT) are causing for people with pancreatic cancer. We know how important PERT is for controlling symptoms and maintaining people’s quality of life and we have spoken to The Sun about the problems people are facing in accessing this vital medication.  

Pancreatic cancer can affect the body’s ability to properly digest food, meaning that nutrients are not absorbed. Taking PERT allows people with pancreatic cancer to digest food, maintain a healthy weight, and be well enough to tolerate treatment, such as chemotherapy.  

The shortages are being caused by disruption to the manufacturing process for the main supplier of PERT. We are adding all the latest news as we get it to our PERT blog, which you can read here. 

We have been discussing this worrying situation with officials and PERT suppliers, pushing them to prioritise and address the shortages. PERT is as essential for people with pancreatic cancer as insulin is for people with diabetes and a proactive plan is needed to address the shortages and the impact these are having on our community. 

If you or a loved one are struggling, we are here to help you. We have worked with healthcare professionals to develop specific, expert advice on how to manage your PERT during this difficult situation. You can find their advice here.  

Please get in touch if you need support. Our team of specialist nurses are only a phone call away. They are all experts in pancreatic cancer and can help you through this – whether you’re completely new to PERT or have been taking it for years. To speak to a nurse, call our Support Line on 0808 801 0707 or email nurse@pancreaticcancer.org.uk.